Jeffrey Leiden (investor - None)
See something wrong or missing? Let us know
Offices:Boston
Dr. Jeffrey Leiden is the Executive Chairman of Vertex Pharmaceuticals.
Average round investment:N/A USD
Average number per year:0.0
Investors with similar profile to Jeffrey Leiden
| Name | Criteria | |
|---|---|---|
 |
Håkan Jeppsson
20%
|
|
 |
Alfonso Cortina de Alcocer
20%
|
|
|
Alpha Nordic Capital
20%
|
|
|
AnaCap Financial Partners
20%
|
|
|
 |
Astyanax Kanakakis
20%
|
|
|
Daniel Döderlein
20%
|
|
|
 |
Bredvid AS
20%
|
|
 |
Ib Kunøe
20%
|
|
|
Christian Clausen
20%
|
|
|
Christian Eriksen
20%
|
|
Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Lithuania
France
Ireland
Italy
Portugal
United Kingdom